000			a
999			_c11473 _d11473
003			OSt
005			20200922102252.0
008			200922b xxu||||| |||| 00| 0 eng d
040			_aAIKTC-KRRC _cAIKTC-KRRC
100			_912573 _aAlbarraq, Ahmed A.
245			_aPrevalence and Pharmacotherapeutic Management of Pediatric Psoriasis _b:A Descriptive Review
250			_aVol.53(4), Oct-Dec
260			_aKarnataka _bIndian journal of pharmaceutical education and research _c2019
300			_a569-576p.
520			_aPsoriasis is an auto-immune chronic inflammatory skin disease, which affects about 3.5% of the world’s population. Prevalence of psoriasis among children aged 0 to 18 years is 1% in the United State of America, 5.3% in eastern Saudi Arabia and is on constant rise in other parts of the world. An effective treatment of psoriasis in children may often be challenging mainly because of the lack of established therapeutic guidelines. The objective of this review, therefore, is to provide an update on the prevalence and the pharmacotherapeutic management of pediatric psoriasis, which could be beneficial to clinical pharmacists and other healthcare workers. This multifactorial papulosquamous disorder is linked with the genetic makeup of an individual although the various risk factors like obesity, stress, emotional imbalance, psychological disturbances, cold weather, skin irritation, infection in the respiratory tract and the presence of hemolytic streptococcus could trigger psoriasis. Plaque psoriasis is the most common; but, guttate, pustular disease, erythrodermic (red skin) and rheumatoid psoriasis diseases are also noticed in children. The successful approach for treating psoriasis in children depends on the precise selection of line of therapy on case-by-case basis to enhance benefit-risk ratio, with careful attention of its impact on the patient and family. Therefore, treatment of pediatric psoriasis must be rationalized based on the type and intensity of the disease to reduce probable side effects of drugs in children.
650		0	_94639 _aPHARMACEUTICS
700			_912574 _aAlqabtani, Saad S.
773	0		_x0019-5464 _tIndian journal of pharmaceutical education and research _dBengluru Association of Pharmaceutical Teachers of India (APTI)
856			_uhttps://www.ijper.org/sites/default/files/IndJPhaEdRes_53_4_569.pdf _yClick here
942			_2ddc _cAR